resveratrol has been researched along with fluorescein-5-isothiocyanate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmann, L; Metzler, M; Schmitt, E; Stopper, H | 1 |
| Balapure, AK; Nigam, M; Ranjan, V; Rath, SK; Sharma, R; Singh, N | 1 |
| Barbosa, JP; Barbosa, MA; Neves, AR; Reis, MS; Santos, SG; Silva, AM | 1 |
| Jahan, S; Khanna, VK; Kumar, D; Kumar, V; Pandey, A; Pant, AB; Rajpurohit, CS; Singh, S; Srivastava, A | 1 |
| Abdelaziz, GM; Abu El-Asrar, AM; Ahmad, A; De Hertogh, G; Mohammad, G; Siddiquei, MM | 1 |
| Annamalai, P; Gower, RM; Hendley, MA; Isely, C; Jabbari, E; Kader, S; Murphy, KP | 1 |
6 other study(ies) available for resveratrol and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Hormonal and genotoxic activity of resveratrol.
Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Fluorescein-5-isothiocyanate; Humans; Kinetochores; Lymphoma; Metaphase; Mice; Micronucleus Tests; Molecular Structure; Protein Binding; Receptors, Estrogen; Resveratrol; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured | 2002 |
Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells.
Topics: Annexin A5; Anticarcinogenic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorimetry; Cyclophosphamide; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Resveratrol; Stilbenes | 2009 |
Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.
Topics: Antigens, CD; CD83 Antigen; Cell Differentiation; Dendritic Cells; Drug Carriers; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Immune Tolerance; Immunoglobulins; Interleukin-12; Lipids; Membrane Glycoproteins; Monocytes; Nanostructures; NF-kappa B; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |
Resveratrol Prevents the Cellular Damages Induced by Monocrotophos via PI3K Signaling Pathway in Human Cord Blood Mesenchymal Stem Cells.
Topics: Adult; Annexin A5; Antioxidants; Biomarkers; Cell Death; Cytoprotection; Fetal Blood; Fluorescein-5-isothiocyanate; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mesenchymal Stem Cells; Mitochondria; Models, Biological; Monocrotophos; Neurons; Phosphatidylinositol 3-Kinases; Propidium; Protective Agents; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2018 |
Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Blotting, Western; Dextrans; Diabetic Retinopathy; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immunohistochemistry; Intravitreal Injections; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Vitreous Body | 2019 |
Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Delayed-Action Preparations; Drug Liberation; Fluorescein-5-isothiocyanate; Mice; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Resveratrol | 2019 |